Stay updated with breaking news from Peter Rizakos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC Pink: BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30, 2023. Numbers show:
Braxia Scientific Corp. , a medical research company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its...
Compass Launches Center Of Excellence Compass Pathways (NASDAQ:CMPS) officially launched the Centre of Excellence, in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland. This “clinic model” will study and build the best therapy models for psychedelics treatment and work as a site for clinical trials as well as a laboratory for innovation. It will also explore research around COMP360, Compass’ psilocybin drug candidate. Scott Aaronson MD, Director of Clinical Research at Sheppard Pratt, will lead the center. “Sheppard P...
Champignon Brands Announces New CFO and New General Counsel News provided by Share this article Leadership of Chairman and CEO Dr. Roger McIntyre VANCOUVER, BC, Jan. 11, 2021 /PRNewswire/ - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), Chairman and CEO Roger McIntyre today announced the Company's appointment of Stephen R. Brooks as its new Chief Financial Officer and Peter Rizakos as the firm's new General Counsel. These appointments complete the Company's new top management team put into place by Dr. McIntyre and the Champignon Board of Directors. Dr. Mc...